Here's how much Warren Buffett is up on his UnitedHealth stock bet

Berkshire Hathaway disclosed a new $1.57 billion investment in UnitedHealth (UNH) during Q2 2025, acquiring 5,039,564 shares at an average price of $311.97. This position has already yielded a paper gain of approximately $210 million, with UNH stock climbing 13.35% since the purchase and experiencing a broader 30% surge, partly attributed to the 'Buffett effect.' Analysts interpret this move as a classic value play by Buffett, capitalizing on a significant price decline in a market-leading company perceived as undervalued relative to its fundamentals.

Analysis

Berkshire Hathaway's Q2 2025 13F filing revealed a significant new position in UnitedHealth Group, comprising 5,039,564 shares acquired for $1.57 billion at an average price of $311.97. This investment is already demonstrating substantial paper gains, with UNH closing at $353.61, representing a 13.35% increase from Berkshire's entry point and translating to a gain of approximately $210 million. The disclosure has triggered a pronounced 'Buffett effect,' causing the stock to surge over 30% from its pre-disclosure price of $271.49 as market participants followed the trade. The strategic rationale appears to be a classic value play, capitalizing on the stock's nearly 60% decline from its 52-week high of $621.24. By acquiring a market leader with stable cash flows at a significant discount, Berkshire has signaled a belief that the company was deeply undervalued relative to its long-term fundamentals, rather than making a simple defensive bet on the healthcare sector.

Key Decisions for Investors

• Investors may view Berkshire Hathaway's substantial investment as a strong validation of UnitedHealth's fundamental value, suggesting potential for further appreciation even after the recent rally.
• Given that the stock has surged over 30% since the disclosure, investors should be aware that a portion of this gain is attributable to the 'Buffett effect' and momentum flows, which may require sustained fundamental performance to support the new valuation level.
• Prospective investors should carefully consider their entry point, as the current price is significantly above Berkshire's discounted purchase price of $311.97, implying a reduced margin of safety compared to what was available at the recent lows.